Background and Importance Telepharmacy promotes continuous and quality health care based on the use of new technologies.

Useful in patients with chronic diseases that require a pharmacovigilance programme, such as HIV patients.

Aim and Objectives To determine if a telepharmacy model, improves the perceived HIV patient experience compared to a traditional (face-to-face) model of health care.

Material and Methods Prospective observational interventional study (January to August 2022). Included 35 HIV patients with antiretroviral treatment (ART) of legal age under follow-up by the pharmacist, with access to technologies to receive telepharmacy assistance and who gave their consent.

The study was divided into 2 stages: T-4 pre-implementation of telepharmacy (January to April 2022), T+4 post-telepharmacy (May to August 2022).

Patients were recruited during the T-4 period in the pharmaceutical care office, where they were given the questionnaire: Instrument for the Evaluation of Chronic Patient eXperience (IEXPAC), a 15-item questionnaire with 11 global questions and 4 conditional questions, which makes it possible to assess the patient’s perceived experience of health care.

The SPSS^®program and Wilcoxon test assessed whether there are differences in the IEXPAC (global and conditional) in the same population before and after implementing a telepharmacy programme.

Other stratification data were: sex, age, time since diagnosis and number of tablets per day.

Results 35 patients were included (100% male), median age 53 years (31-72), 97.6% took one tablet daily, median disease evolution 17 years (0.5-33).

4 telematic consultations were carried out with each patient.

Global IEXPAC: 27 patients had a better experience, 8 remained the same. Conditional IEXPAC: 30 patients had a better experience and 5 remained the same. The Wilcoxon test compared the results of IEXPAC before and after implementing a telepharmacy programme (p<0.01).

Conclusion and Relevance The implementation of telepharmacy programmes improves the experience perceived by HIV patients of pharmaceutical care.

Telepharmacy could be a useful tool for the control and pharmacotherapeutic follow-up of HIV patients and other pathologies, avoiding unnecessary trips by vulnerable patients who have difficulty in going to the hospital.

Conflict of Interest No conflict of interest